Form 4: Traws Pharma CFO Mark Guerin Reports Stock Transactions
SEC Form 4 Filing
Mark Guerin, CFO of Traws Pharma, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On June 10, 2024, Mark Guerin, CFO of Traws Pharma, exercised 5,500 restricted stock units (RSUs) that converted into common stock on a one-for-one basis.
- These RSUs were part of a grant of 16,500 RSUs from June 10, 2022, vesting over three years.
- On June 18, 2024, 2,221 shares were disposed of at a price of $0.47 for tax withholding purposes.
- Following these transactions, Guerin directly owns 39,255 shares of common stock and 5,500 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company insider, with no inherently positive or negative implications.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings provide transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 06/10/2022 | Reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary |
| 06/10/2024 | 5,500 restricted stock units converted into common stock. |
| 06/18/2024 | 2,221 shares disposed of for tax withholding at $0.47 per share. |
| 06/20/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.